Title : Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.

Pub. Date : 2015 Nov 3

PMID : 26457538






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus. Metformin dipeptidyl peptidase 4 Homo sapiens
2 CONCLUSION: Compared with sulfonylureas, DPP-4 inhibitors were associated with lower risks for all-cause death, MACEs, ischemic stroke, and hypoglycemia when used as add-ons to metformin therapy. Metformin dipeptidyl peptidase 4 Homo sapiens